Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl S Goodyear

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: overviewCarl S Goodyear, Gregg J Silverman
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2004
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytesCarl S Goodyear, Gregg J Silverman
Trends in Immunology|June 18, 2013
Glycolipid antigens and autoantibodies in autoimmune neuropathiesHugh J Willison, Carl S Goodyear
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: stage 1, generating librariesCarl S Goodyear, Gregg J Silverman
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: stage 3, binding analysisCarl S Goodyear, Gregg J Silverman
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: stage 2, panningCarl S Goodyear, Gregg J Silverman
Nature Reviews. Immunology|May 26, 2006
Confounding B-cell defences: lessons from a staphylococcal superantigenGregg J Silverman, Carl S Goodyear
The Journal of Experimental Medicine|April 30, 2003
Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal ToxinCarl S Goodyear, Gregg J Silverman
Clinical Immunology (Orlando, Fla.)|February 16, 2002
A model B-cell superantigen and the immunobiology of B lymphocytesGregg J Silverman, Carl S Goodyear
Springer Seminars in Immunopathology|January 6, 2005
B cell superantigens: a microbe's answer to innate-like B cells and natural antibodiesCarl S Goodyear, Gregg J Silverman
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: overviewCarl S Goodyear, Gregg J Silverman
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2004
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytesCarl S Goodyear, Gregg J Silverman
Trends in Immunology|June 18, 2013
Glycolipid antigens and autoantibodies in autoimmune neuropathiesHugh J Willison, Carl S Goodyear
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: stage 1, generating librariesCarl S Goodyear, Gregg J Silverman
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: stage 3, binding analysisCarl S Goodyear, Gregg J Silverman
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: stage 2, panningCarl S Goodyear, Gregg J Silverman
Nature Reviews. Immunology|May 26, 2006
Confounding B-cell defences: lessons from a staphylococcal superantigenGregg J Silverman, Carl S Goodyear
The Journal of Experimental Medicine|April 30, 2003
Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal ToxinCarl S Goodyear, Gregg J Silverman
Clinical Immunology (Orlando, Fla.)|February 16, 2002
A model B-cell superantigen and the immunobiology of B lymphocytesGregg J Silverman, Carl S Goodyear
Springer Seminars in Immunopathology|January 6, 2005
B cell superantigens: a microbe's answer to innate-like B cells and natural antibodiesCarl S Goodyear, Gregg J Silverman
Pageof 10